The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International journal of pharmaceutics

• Publication date

  2004-11-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJPHARM.2004.08.001PMID 15488686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanosizing: a formulation approach for poorly-water-soluble compounds.

  2003cited by this paper
• The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

  2003cited by this paper
• Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

  2003cited by this paper
• A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

  2002cited by this paper
• Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.

  2002cited by this paper
• Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.

  2001cited by this paper
• Formulation and Physiological and Biopharmaceutical Issues in the Development of Oral Lipid-Based Drug Delivery Systems

  2001cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications.

  2000cited by this paper
• Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities

  2000cited by this paper
• Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration

  1999cited by this paper
• Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

  1999cited by this paper
• Reduced Systemic Availability of an Antiarrhythmic Drug, Bidisomide, with Meal Co-administration: Relationship with Region-Dependent Intestinal Absorption

  1998cited by this paper
• Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

  1997cited by this paper
• Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

  1997cited by this paper
• Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

  1995cited by this paper
• Chronic catheterization of the intestines and portal vein for absorption experimentation in beagle dogs.

  1995cited by this paper
• Effect of Food on the Oral Bioavailability of Isosorbide‐5‐Mononitrate Administered as an Extended‐Release Tablet

  1995cited by this paper
• Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats

  1995cited by this paper
• Effect of food on the relative bioavailability of a hypolipidemic agent (CGP 43371) in healthy subjects.

  1994cited by this paper
• Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region.

  1993cited by this paper
• Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.

  1993cited by this paper
• Aqueous acidic degradation of the carbacephalosporin loracarbef.

  1993cited by this paper
• Effect of hydroxypropylmethylcellulose on gastrointestinal transit and luminal viscosity in dogs.

  1991cited by this paper
• Nutrient effects on intestinal drug absorption.

  1990cited by this paper
• Effects of food on drug absorption.

  1989cited by this paper
• Transit of pharmaceutical dosage forms through the small intestine.

  1986cited by this paper
• Mixing-tank model for predicting dissolution rate control or oral absorption.

  1986cited by this paper
• Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.

  1985cited by this paper
• Physicochemical model for dose-dependent drug absorption.

  1984cited by this paper

• Advanced Drug Delivery Strategies to Overcome Solubility and Permeability Challenges: Driving Biopharmaceutical Advancements Toward Commercial Success

  2025cites this paper
• Hydroxypropyl cellulose-based lyospheres accelerate dissolution of aprepitant combined with its supersaturation for oral delivery.

  2025cites this paper
• Nanocrystal Drug Delivery Systems Significantly Enhance the Therapeutic Efficacy of Anticancer Agents

  2025cites this paper
• Enhancing solubility, bioavailability and anti-cancer efficacy of aprepitant through a naringin-based co-amorphous system

  2025cites this paper
• Role of Drug Loading and Microenvironmental pH in Generation of Nanospecies during Dissolution of Eudragit-Based Amorphous Solid Dispersions.

  2025cites this paper
• Impact of chain-length of sulfhydryl-modified surface-decorated surfactants on mucoadhesive nanostructured lipid carriers

  2025cites this paper
• Toward Next-Generation Ingestible Hydrogels.

  2025cites this paper
• Ex vivo permeability study of poorly soluble drugs across gastrointestinal membranes: acceptor compartment media composition.

  2024cites this paper
• The use of population pharmacokinetics to extrapolate food effects from human adults and beagle dogs to the pediatric population illustrated with ibuprofen as a case.

  2024cites this paper
• Experimental solubility of omeprazole in pure and ethanol-modified subcritical water

  2024cites this paper
• PHARMACEUTICAL NANOCRYSTALS: AN EXTENSIVE OVERVIEW

  2024cites this paper
• Mucoadhesive aprepitant-loaded nanostructured lipid carriers containing sulfhydryl surfactant for enhanced oral drug bioavailability

  2024cites this paper
• Development of a canine artificial colonic mucus model for drug diffusion studies.

  2024cites this paper
• Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate

  2024cites this paper
• Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration

  2024cites this paper
• Evaluating physiochemical properties of FDA-approved orally administered drugs

  2023influential citation
• The Use of Population Pharmacokinetics to Extrapolate Food Effects from Human Adults and Beagle Dogs to the Pediatric Population Illustrated with Paracetamol as a Test Case

  2023cites this paper
• Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex

  2023influential citation
• Assessment of food effects during clinical development.

  2023cites this paper
• Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations.

  2023cites this paper
• Biopharmaceutical Modeling of Food Effect─Exploring the Role of Dietary Fat.

  2023cites this paper
• Usefulness of the Beagle Model in the Evaluation of Paracetamol and Ibuprofen Exposure after Oral Administration to Pediatric Populations: An Exploratory Study.

  2023cites this paper
• Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles

  2022cites this paper
• Nanomaterials: A Comprehensive Review of Applications, Toxicity, Impact, and Fate to Environment

  2022cites this paper
• Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects

  2022cites this paper
• Bio-enabling strategies to mitigate the pharmaceutical food effect: a mini review.

  2022cites this paper
• Fabrication of an aprepitant nanosuspension using hydroxypropyl chitosan to increase the bioavailability.

  2022cites this paper
• A Simple One-Parameter Percent Dissolved Versus Time Dissolution Equation that Accommodates Sink and Non-sink Conditions via Drug Solubility and Dissolution Volume

  2022cites this paper
• Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer

  2022cites this paper
• Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant

  2022cites this paper
• Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF

  2022cites this paper
• In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug

  2021cites this paper
• Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation

  2021cites this paper
• Application of Fundamental Techniques for Physicochemical Characterizations to Understand Post-Formulation Performance of Pharmaceutical Nanocrystalline Materials

  2021cites this paper
• An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers.

  2021cites this paper
• Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trends

  2021cites this paper
• Experimental study and modeling of letrozole (anticancer drug) solubility in subcritical water: Production of nanoparticles using subcritical water precipitation method

  2021cites this paper
• Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

  2021cites this paper
• Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs

  2021cites this paper
• Enabling formulations of aprepitant: in vitro and in vivo comparison of nanocrystalline, amorphous and deep eutectic solvent based formulations

  2021influential citation
• Harnessing the potential of nanostructured formulations to mimic the food effect of lurasidone.

  2021cites this paper
• Biopharmaceutical considerations in the pediatric and geriatric formulation development

  2021cites this paper
• Solubility measurement and preparation of nanoparticles of ampicillin using subcritical water precipitation method

  2021cites this paper
• Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach

  2021cites this paper
• Role of solid lipid nanoparticles as drug delivery vehicles on the pharmacokinetic variability of Erlotinib HCl

  2021cites this paper
• Enhanced transdermal permeation of BCS class IV aprepitant using binary ethosome: Optimization, characterization and ex vivo permeation

  2020cites this paper
• Design and Characterization of Phosphatidylcholine-Based Solid Dispersions of Aprepitant for Enhanced Solubility and Dissolution

  2020cites this paper
• Simultaneous determination of donepezil, 6-O-desmethyl donepezil and spinosin in beagle dog plasma using liquid chromatography‒tandem mass spectrometry and its application to a drug-drug interaction study.

  2020cites this paper
• Delivering anticancer drugs as carrier-free nanocrystals

  2020cites this paper
• A Review On Nanocrystals In Drug Delivery

  2020cites this paper
• Challenges and opportunities in the delivery of cancer therapeutics: update on recent progress.

  2020cites this paper
• Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models

  2020cites this paper
• Systematic screening of pharmaceutical polymers for hot melt extrusion processing.

  2020cites this paper
• Salinomycin nanocrystals for colorectal cancer treatment through inhibition of Wnt/β-catenin signaling.

  2020cites this paper
• Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective

  2020cites this paper
• Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs

  2020cites this paper
• Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes.

  2020cites this paper
• Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors

  2020cites this paper
• Simple Liquid Chromatography–Tandem Mass Spectrometry Method for Quantitation of Total and Free Aprepitant and Its Active N-Dealkylated Metabolites in Human Plasma

  2020cites this paper
• Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states.

  2019influential citation
• A detailed canine brain label map for neuroimaging analysis

  2019cites this paper
• Nanoparticles for improvement in oral bioavailability

  2019cites this paper
• UTILIZING NANO PARTICULATE FORMULATIONS IN THE DELIVERY OF POORLY SOLUBLE DRUGS

  2019cites this paper
• Development, preclinical evaluation and first-in-human clinical trial of a nano-amorphous abiraterone acetate formulation

  2019cites this paper
• Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs.

  2019cites this paper
• Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule

  2019cites this paper
• Drug nanocrystals: Fabrication methods and promising therapeutic applications.

  2019cites this paper
• Evaluation of Dissolution Enhancement of Aprepitant [0.95]Drug in Ternary Pharmaceutical Solid Dispersions with [0.95]Soluplus® and Poloxamer 188 Prepared by Melt Mixing

  2019cites this paper
• Food for thought: formulating away the food effect – a PEARRL review

  2019cites this paper
• Evaluation of Dissolution Enhancement of Aprepitant Drug in Ternary Pharmaceutical Solid Dispersions with Soluplus® and Poloxamer 188 Prepared by Melt Mixing

  2019cites this paper
• Bioavailability enhancement of poorly soluble drugs: The holy grail in pharma industry.

  2019cites this paper
• State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation

  2019cites this paper
• Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults

  2019cites this paper
• Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer

  2018cites this paper
• Formulation development of drug nanocrystals and nanoparticles for dermal delivery

  2018cites this paper
• Intestinal absorption of drugs The impact of regional permeability , nanoparticles , and absorption-modifying excipients

  2018cites this paper
• Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans.

  2018cites this paper
• Preparation of Aprepitant nanoparticles (efficient drug for coping with the effects of cancer treatment) by rapid expansion of supercritical solution with solid cosolvent (RESS-SC)

  2018cites this paper
• Production of pure drug nanocrystals and nano co‐crystals by confinement methods☆

  2018cites this paper
• The potential of synergism between ultrasonic energy and Soluplus® as a tool for solubilization and dissolution enhancement of a poorly water soluble drug. A statistically based process optimization

  2018cites this paper
• Effects of particle size, surface nature and crystal type on dissolution rate,.

  2018cites this paper
• Formulation Strategies and Practice Used for Drug Candidates with Water-Insoluble Properties for Toxicology, Biology, and Pharmacology Studies in Discovery Support

  2018cites this paper
• Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments

  2018cites this paper
• Salt formation improved the properties of a candidate drug during early formulation development

  2018cites this paper
• Pharmaceutical nanocrystals: production by wet milling and applications.

  2018cites this paper
• Solid Oral Flexible Formulations for Pediatric and Geriatric patients: Age-appropriate Formulation Platforms

  2018cites this paper
• Amorphous magnesium carbonate nanomaterials : Synthesis, characterization and applications

  2018cites this paper
• Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.

  2018cites this paper
• Preparation and characterization of adefovir dipivoxil–stearic acid cocrystal with enhanced physicochemical properties

  2018cites this paper
• Food Effect on Oral Bioavailability: Old and New Questions

  2017cites this paper
• Solubility of Pharmaceutical Solids

  2017cites this paper
• Development Considerations for Nanocrystal Drug Products

  2017cites this paper
• ON NANOCRYSTAL Dip

  2017cites this paper
• Production of aprepitant nanocrystals by wet media milling and subsequent solidification.

  2017cites this paper
• BCS class IV drugs: Highly notorious candidates for formulation development

  2017cites this paper
• Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs

  2017cites this paper
• Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials

  2017cites this paper
• Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming

  2017cites this paper
• Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.

  2017cites this paper
• Formation of Mefenamic Acid Nanocrystals with Improved Dissolution Characteristics

  2017cites this paper